Digital Content 
NEWS #PharmaBuzz
18 Aug 2025
// PRESS RELEASE
https://ir.tonixpharma.com/news-events/press-releases/detail/1585/tonix-pharmaceuticals-announces-fda-approval-of
15 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/15/3134450/28908/en/Tonix-Pharmaceuticals-Announces-FDA-Approval-of-Tonmya-cyclobenzaprine-HCl-sublingual-tablets-for-the-Treatment-of-Fibromyalgia.html
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112862/28908/en/Tonix-Pharmaceuticals-Announces-On-line-Publication-of-Phase-3-RESILIENT-Trial-Results-of-TNX-102-SL-for-Fibromyalgia-in-the-Peer-Reviewed-Journal-Pain-Medicine.html
16 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/16/3099705/28908/en/Tonix-Pharmaceuticals-Presented-Data-and-Analyses-of-TNX-102-SL-Treatment-Effects-on-Fibromyalgia-at-the-Annual-European-Congress-of-Rheumatology-EULAR-2025.html
07 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/07/3056558/28908/en/Tonix-Pharmaceuticals-Presented-Data-and-Analyses-of-TNX-102-SL-Treatment-Effects-on-Fibromyalgia-at-the-American-Academy-of-Pain-Medicine-AAPM-2025-Annual-Meeting.html
04 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/04/3036329/28908/en/Tonix-Pharmaceuticals-Presented-Data-and-Analyses-of-TNX-102-SL-Treatment-Effects-on-Fibromyalgia-at-7th-International-Congress-on-Controversies-in-Fibromyalgia.html
Share 